Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term follow-up of the Dutch Turner Oxandrolone Study
NL-OMON27906Recruiting
- Sponsor
- Pfizer
- Start
- Aug 2009
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of oxandrolone, somatropin and DehydraTECH-estrogen in Turner syndrome (TS) (2 arms), sponsored by Pfizer. Primary endpoint: Final adult height. Started Aug 2009; status: recruiting.
02
Drugs
oxandrolonesomatropinDehydraTECH-estrogen
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on NL-OMON27906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27906.